Tagged wockhardt

Press Release

Wockhardt Launches Generic Version Of Anti-Depressant Drug Wellbutrin® SR

 Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 100 mg, 150 mg and 200 mg 12-Hr extended release tablets of Bupropion HCl Read More
Press Release

Wockhardt Receives Tentative US FDA Approval For Generic Version Of Anti-Psychotic Drug Geodon®

 Pharmaceutical and biotechnology major Wockhardt has received tentative US FDA approval for marketing a generic version of 20mg, 40mg, 60mg & 80mg capsules containing Ziprasidone hydrochloride Read More
Press Release

Wockhardt To Launch Generic Version Of BPH Drug Uroxatral®

 Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 10mg extended release tablets of Alfuzosin hydrochloride Read More
Press Release

Wockhardt Honoured With 2012 DIANA Award For Best Overall Generic Manufacturer

 HDMA recognizes Wockhardt's Excellence at its 2012 Business & Leadership Conference Read More
Press Release

Wockhardt Launches Authorized Generic Of Parkinson's Drug Stalevo® With 180-Days Exclusivity

 Pharmaceutical and biotechnology major Wockhardt has launched an authorized generic version of four strengths (50mg, 75mg, 125mg and 200mg) of the triple-drug Read More